Gastrointestinal Cancers and Clinical Trials: What Patients Need to Know Earlier On
-
May 20, 2026
-
9 min
May 20, 2026
Researchers screened 1,758 de novo protein binders and identified design features that influence CAR T cell activation, specificity, and tumor control
September 15, 2026
All 16 patients who received TG4050 after standard treatment remained disease-free, compared with 13 of 16 patients in the control group
September 16, 2026